As the AST and ALT are the significant liver injury biomarkers [46], our results suggested that TM6SF2 rs58542926 T allele was associated with the hepatic TG accumulation, therefore leads to the decreased serum lipid profiles, and promotes the liver injury in NAFLD patients. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.